Vanda Pharmaceuticals Inc. (VNDA): Price and Financial Metrics

VNDA POWR Grades

• VNDA scores best on the Value dimension, with a Value rank ahead of 98.64% of US stocks.
• The strongest trend for VNDA is in Momentum, which has been heading down over the past 48 weeks.
• VNDA ranks lowest in Momentum; there it ranks in the 5th percentile.

VNDA Stock Summary

• VNDA's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 75.71 -- higher than 72.2% of US-listed equities with positive expected earnings growth.
• The ratio of debt to operating expenses for Vanda Pharmaceuticals Inc is higher than it is for about just 9.85% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.17 for Vanda Pharmaceuticals Inc; that's greater than it is for just 11.12% of US stocks.
• Stocks that are quantitatively similar to VNDA, based on their financial statements, market capitalization, and price volatility, are DIOD, SCWX, PCTI, CAMT, and DGII.
• Visit VNDA's SEC page to see the company's official filings. To visit the company's web site, go to www.vandapharma.com.

VNDA Valuation Summary

• In comparison to the median Healthcare stock, VNDA's price/earnings ratio is 21.37% lower, now standing at 28.7.
• VNDA's price/sales ratio has moved NA NA over the prior 187 months.
• Over the past 187 months, VNDA's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for VNDA.

VNDA Growth Metrics

• The 5 year net income to common stockholders growth rate now stands at 161.25%.
• Its 3 year price growth rate is now at 81.81%.
• Its 5 year price growth rate is now at 12.19%.

VNDA's revenue has moved up $108,359,000 over the prior 52 months.

The table below shows VNDA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	258.529	56.886	32.44
2021-03-31	252.837	61.875	31.501
2020-12-31	248.168	51.775	23.337
2020-09-30	241.445	42.264	19.363
2020-06-30	240.622	38.888	113.839
2020-03-31	237.475	35.397	116.651

VNDA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VNDA has a Quality Grade of B, ranking ahead of 90.38% of graded US stocks.
• VNDA's asset turnover comes in at 0.479 -- ranking 92nd of 677 Pharmaceutical Products stocks.
• NEOG, SBBP, and AMGN are the stocks whose asset turnover ratios are most correlated with VNDA.

The table below shows VNDA's key quality metrics over time.